Viewing StudyNCT00345579



Ignite Creation Date: 2024-05-05 @ 4:56 PM
Last Modification Date: 2024-10-26 @ 9:25 AM
Study NCT ID: NCT00345579
Status: COMPLETED
Last Update Posted: 2016-12-16
First Post: 2006-06-26

Brief Title: Safety of Hib-MenCY-TT Vaccine Versus Licensed Hib Conjugate Vaccine Given at 2 4 6 and 12 to 15 Months of Age
Sponsor:
Organization: GlaxoSmithKline

Study Design

Study Type: INTERVENTIONAL
Expanded Access Type Individual: None
Expanded Access Type Intermediate: None
Expanded Access Type Treatment: None
Patient Registry: None
Target Duration: None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention: None
Bio Spec Description: None
Enrollment Count: 4432
Enrollment Type: ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Name
PHASE3
Observational Models:
Time Perspective List:
Who Masked List: